1-3 of 3
Ujwal Shinde
Close
Sort by
Journal Articles

Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML

Clinical Trials & Observations
Fei Yang, Nicola Long, Tauangtham Anekpuritanang, Daniel Bottomly, Jonathan C. Savage, Tiffany Lee, Jose Solis-Ruiz, Uma Borate, Beth Wilmot, Cristina Tognon, Allison M. Bock, Daniel A. Pollyea, Saikripa Radhakrishnan, Srinidhi Radhakrishnan, Prapti Patel, Robert H. Collins, Srinivas Tantravahi, Michael W. Deininger, Guang Fan, Brian Druker, Ujwal Shinde, Jeffrey W. Tyner, Richard D. Press, Shannon McWeeney, Anupriya Agarwal
Journal: Blood
Blood (2022) 139 (8): 1208–1221.
https://doi.org/10.1182/blood.2021011354
Published: 2022
Includes: Supplemental data
Journal Articles

Pacritinib Targets IRAK1 and Shows Synergy with HDAC and BET Inhibitors in Acute Myeloid Leukemia

Alka Puri, PhD, Shawn Mahmood, B.S., B.A., Bernadette Maertens, Monika Davare, PhD, Stephen E Kurtz, PhD, Cristina E. Tognon, Christopher O. Eden, BA, Johannes Elferich, PhD, Ujwal Shinde, PhD, Brian J. Druker, MD, Jack W. Singer, Anupriya Agarwal
Journal: Blood
Blood (2016) 128 (22): 3514.
https://doi.org/10.1182/blood.V128.22.3514.3514
Published: 2016
Journal Articles

Pacritinib, a Dual FLT3/JAK2 Inhibitor, Reduces Irak-1 Signaling in Acute Myeloid Leukemia

Megan M Cleary, B.S., B.A., Rhese Thompson, Shawn Mahmood, B.S., B.A., Monika Davare, PhD, Steve Kurtz, PhD, Johannes Elferich, PhD, Ujwal Shinde, PhD, Brian J. Druker, MD, Jack Singer, MD, Anupriya Agarwal, PhD
Journal: Blood
Blood (2015) 126 (23): 570.
https://doi.org/10.1182/blood.V126.23.570.570
Published: 2015